GLP-1 Drug Shortages and Compounding July 2024 IPD has released a new podcast episode, GLP-1 Drug Shortages and Compounding," where Alyssa Guest, PharmD, discusses the glucagon-like peptide-1 (GLP-1) drugs and how interest in weight loss, viral social media posts, celebrity endorsements, illegitimate compounding, and drug shortages have all impacted access to GLP-1s
The Pivot from Drug Registration to GRAS (20072014) 2007: conclusion of the prescription-drug program
Vitamin C: A powerful antioxidant, vitamin C brightens the skin and protects against environmental damage
Injection Method
Safety and Tolerability: Where They Diverge Both compounds share the tolerability profile typical of appetite-suppressing metabolic peptides, but retatrutide carries additional signals that trace directly to its glucagon arm
Like similar drugs, MariTide acts as a glucagon-like peptide-1 (GLP-1) receptor agonist, which in simple terms means it targets the GLP-1 receptors in the brain and pancreas to reduce appetite and control blood sugar
